The Board of Trustees serves as WMIS’s governing body, providing overall direction and supervision of the organization. This election will select seven new trustees to serve three-year terms. Trustees must be full WMIS members in good standing, and their selection aims to balance representation between clinical and basic scientists while reflecting the geographical diversity of the membership.
Meet the Nominees
The nominees below are presented in alphabetical order by last name
Scientific Director, Bristol Myers Squibb
David J. Donnelly, PhD
Areas of expertise:
- PET radioligand discovery
- Immuno-oncology imaging
- Radiopharmaceutical research
Founder and Molecular-imaging Scientist, Xodus Imaging
Mohammed Farhoud, MSc, MBA
Areas of expertise:
- Clinical and Preclinical imaging across a wide range of modalities
- GLP and GMP in radiopharmaceutical evaluation and production
- Imaging-system commercialization
Tenured Senior Investigator and Chief, Neuroradiology Section; Director, Center for Infectious Disease Imaging, Clinical Center, NIH (Intramural Research Program).
Dima A. Hammoud, MD
Areas of expertise:
- Molecular imaging of Infection
- Radiotracer development (pathogen-specific)
- Preclinical and translational PET/CT imaging
Associate Professor, Nuclear Medicine; Joint Associate Professor, Imaging Physics, The University of Texas MD Anderson Cancer Center
Simone Susanne Krebs, MD, MS
Areas of expertise:
- Theranostic-agent development
- Molecular and cellular imaging
- In-vivo cell tracking
Associate Professor of Radiology and Director, Cyclotron Facility, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis
Michael L. Nickels, PhD
Areas of expertise:
- Radiopharmaceutical development
- PET radionuclide production
- Microfluidic radiochemistry
Professor of Radiology, Oncology, Biomedical Engineering and Electrical Engineering, Johns Hopkins University
Arvind P. Pathak, PhD
Areas of expertise:
- Functional and molecular imaging
- Image-based systems biology
- Bioengineering and Neuroengineerging
Research Associate Professor, Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center
Adam J. Rosenberg, PhD
Areas of expertise:
- PET radiotracer development
- Development and Translation of Small Biologics as Radiopharmaceuticals
- Clinical radiotracer production
Paul L. Carson, PhD Collegiate Professor of Radiology and Director of PET Radiochemistry, University of Michigan Medical School
Peter J. H. Scott, PhD
Areas of expertise:
- PET radiochemistry and radiotracer development
- New technology (Artificial intelligence, high throughout experimentation, virtual reality)
- Neurodegenerative-disease imaging
Professor and Head, Molecular Imaging and Nanotherapeutics Laboratory, Baker Heart and Diabetes Institute; Co-leader, Heart Attack Program and Centre for Cardiometabolic mRNA Therapy
Xiaowei Wang, PhD
Areas of expertise:
- Cardiovascular molecular imaging
- Targeted nanotherapeutics
- Cardiometabolic mRNA therapy
Assistant Professor, Walker Department of Mechanical Engineering; Core Faculty, Nuclear and Radiation Engineering Program, The University of Texas at Austin
Elena Zannoni, PhD
Areas of expertise:
- Nuclear-medicine imaging systems
- Gamma- and X-ray detectors
- Quantitative theranostic imaging